Empty capsules found, Aurobindo Pharma recalls Gabapentin
After finding out that one lot of Gabapentin Capsules 300 mg had empty capsules, Aurobindo Pharma, US, has recalled the lot.
After finding out that one lot of Gabapentin Capsules 300 mg had empty capsules, Aurobindo Pharma, US, has recalled the lot.
According to IMS, the product had an estimated market size of USD 422 million for the twelve months ended June 30.
In a separate statement, the company said it has received approval from the USFDA to market generic version of Hoffmann-La Roche's Boniva injection in the American market. The company's Ibandronate Sodium injection is indicated for the treatment of osteoporosis in postmenopausal women.
Aurobindo Pharma Get FDA Nod for Marketing Nafcillin Injections in US
Aurobindo Pharma revealed that it has received an approval from the US Food and Drug Administration to market Nafcillin injections
Aurobindo Pharma revealed that it has received an approval from the US Food and Drug Administration to market Nafcillin injections
Aurobindo Pharma Receives FDA Approval to Market Generic Narcolepsy Drug
Aurobindo Pharma revealed that it has received approval from the US Food and Drug Administration to manufacture modafinil tablets in the US.
Aurobindo Pharma revealed that it has received approval from the US Food and Drug Administration to manufacture modafinil tablets in the US.
Aurobindo Pharma Receives FDA Approval for Generic Metformin Hydrochloride Tablets
Aurobindo Pharma announced that it has received approval from the FDA to manufacture Metformin Hydrochloride extended release tablets for treating diabetes.
Aurobindo Pharma announced that it has received approval from the FDA to manufacture Metformin Hydrochloride extended release tablets for treating diabetes.
